Benzamil
Benzamil is a potassium-sparing diuretic that acts as an epithelial sodium channel (ENaC) blocker. It is primarily used in the treatment of conditions such as hypertension and edema associated with congestive heart failure, cirrhosis, and nephrotic syndrome. Benzamil is a derivative of amiloride, another potassium-sparing diuretic, and is known for its higher potency in inhibiting ENaC.
Mechanism of Action[edit]
Benzamil works by inhibiting the epithelial sodium channels located in the distal convoluted tubule and collecting ducts of the nephron in the kidney. By blocking these channels, benzamil reduces sodium reabsorption, which leads to decreased water reabsorption and increased excretion of sodium and water. This action helps to lower blood pressure and reduce fluid accumulation in the body. Unlike other diuretics, benzamil does not cause significant loss of potassium, making it a potassium-sparing option.
Clinical Uses[edit]
Benzamil is used in the management of:
- Hypertension
- Edema associated with congestive heart failure, cirrhosis, and nephrotic syndrome
- Liddle syndrome, a rare genetic disorder characterized by excessive sodium reabsorption
Side Effects[edit]
Common side effects of benzamil include:
- Hyperkalemia (elevated potassium levels)
- Hyponatremia (low sodium levels)
- Dizziness
- Headache
- Nausea
Contraindications[edit]
Benzamil should not be used in patients with:
- Hyperkalemia
- Anuria (absence of urine production)
- Severe renal impairment
Pharmacokinetics[edit]
Benzamil is administered orally and is absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the urine. The onset of action is typically within a few hours, and the duration of action can last up to 24 hours.
See Also[edit]
References[edit]
External Links[edit]
-
